Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up

Veera Ahtiainen; Leila Vaalavirta; Mikko Tenhunen; Heikki Joensuu; Hanna Mäenpää

doi:10.1080/0284186X.2020.1785003

Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up

Veera Ahtiainen, Leila Vaalavirta, Mikko Tenhunen, Heikki Joensuu, Hanna Mäenpää

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Acta Oncologica
Volym	59
Nummer	9
Sidor (från-till)	1064-1071
Antal sidor	8
ISSN	0284-186X
DOI	https://doi.org/10.1080/0284186X.2020.1785003
Status	Publicerad - 1 sep. 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1080/0284186X.2020.1785003

Citera det här

@article{6481077ae3cb4115a843f74f50f9705d,

title = "Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up",

keywords = "RADIOACTIVE IODINE THERAPY, LOW-DOSE RADIOIODINE, REMNANT ABLATION, ASSOCIATION GUIDELINES, POSTOPERATIVE ABLATION, I-131, PAPILLARY, CARCINOMA, THYROGLOBULIN, TRIAL, 3122 Cancers",

author = "Veera Ahtiainen and Leila Vaalavirta and Mikko Tenhunen and Heikki Joensuu and Hanna M{\"a}enp{\"a}{\"a}",

year = "2020",

month = sep,

day = "1",

doi = "10.1080/0284186X.2020.1785003",

language = "English",

volume = "59",

pages = "1064--1071",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Taylor & Francis",

number = "9",

}

TY - JOUR

T1 - Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer

T2 - a 13-year follow-up

AU - Ahtiainen, Veera

AU - Vaalavirta, Leila

AU - Tenhunen, Mikko

AU - Joensuu, Heikki

AU - Mäenpää, Hanna

PY - 2020/9/1

Y1 - 2020/9/1

KW - RADIOACTIVE IODINE THERAPY

KW - LOW-DOSE RADIOIODINE

KW - REMNANT ABLATION

KW - ASSOCIATION GUIDELINES

KW - POSTOPERATIVE ABLATION

KW - I-131

KW - PAPILLARY

KW - CARCINOMA

KW - THYROGLOBULIN

KW - TRIAL

KW - 3122 Cancers

U2 - 10.1080/0284186X.2020.1785003

DO - 10.1080/0284186X.2020.1785003

M3 - Article

SN - 0284-186X

VL - 59

SP - 1064

EP - 1071

JO - Acta Oncologica

JF - Acta Oncologica

IS - 9

ER -